Menu

Horizon Therapeutics Public Limited Company HZNP

Full chart Compare
Set alert

Price alert · HZNP

All alert types
116.30 +116.30

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
United States → Revenue: $3.59BRevenue → Gross Profit: $2.71BGross Profit → Net Income: $521.48MGross Profit → Selling, General & Admin: $1.54BGross Profit → Research & Development: $437.96MRevenue → Cost of Revenue: $920.20MGross Profit → Interest Expense: $83.71MGross Profit → Other Expenses: $119.19MGross Profit → Income Tax: $5.45MNon-US → Revenue: $39.53MGross Profit$2.71BCost of Revenue$920.20MNet Income$521.48MSelling, General & Admin$1.54BResearch & Development$437.96MInterest Expense$83.71MOther Expenses$119.19MIncome Tax$5.45MRevenue$3.63BUnited States$3.59BNon-US$39.53M

Latest period ending Dec 31, 2022 · select a line to chart its full history

HZNP annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
3.63B3.23B2.20B1.30B1.21B
2.71B2.43B1.67B937.85M816.27M
611.85M544.92M493.41M125.67M38.75M
521.48M534.49M389.80M573.02M-38.38M
2.222.271.812.90-0.23
HZNP annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
2.36B1.58B2.08B1.08B962.12M
9.11B8.68B6.07B4.44B3.94B
4.04B4.01B2.05B2.25B2.75B
2.56B2.57B1.00B1.35B1.90B
5.07B4.67B4.03B2.19B1.19B
HZNP annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
1.26B1.04B555.69M426.33M194.54M
-134.00M-2.99B-464.07M-17.86M27.65M
-347.96M1.47B904.58M-290.45M-16.60M
-64.03M-74.60M-158.45M-17.86M39.65M
773.43M-499.32M1.00B117.92M204.22M